Your snapshot
Inductive Bio's score and Biomedical & Pharma Research Intelligence position
State-of-the-art ADMET prediction models for drug discovery
Description
Inductive Bio’s absorption, distribution, metabolism, excretion, and toxicity (ADMET) models predict the chemical and pharmacokinetic properties that determine whether a molecule can become a viable drug. When these predictions are surfaced directly in conversation, scientists can evaluate compounds, triage ideas, and prioritize which molecules to synthesize, without leaving their existing workflow. Through this MCP server, users can access Inductive Bio’s models for the physicochemical properties LogD (lipophilicity) and pKa (acid/base ionization), key drivers of solubility and permeability. Inductive’s full suite of models spans all tiers of ADMET assays, including microsomal stability, efflux, CYP inhibition, brain penetration, hERG inhibition, and more. Models are fine-tuned to each customer’s chemical space to advance predictive performance. To access the full suite, reach out to Inductive Bio here: https://www.inductive.bio/book-a-demo.
The Primary Subcategory used for this profile’s headline score.
Other Subcategories where the Integration is listed.
Get updates when Inductive Bio’s Discoverability Score or category rank changes.
Claude Discoverability Score
Live · refreshed daily. Last refreshed#9of 19competitors
Shown to buyers in 0.0% of contested Runs.
One core score. Three important factors to discoverability.
Claude found Inductive Bio in search, but did not show it to users or invoke it.
Inductive Bio organic discovery report
See how Inductive Bio appears in Biomedical & Pharma Research Intelligence, where it ranks, and how it compares with the wider Claude Connector ecosystem.
Your snapshot
Inductive Bio's score and Biomedical & Pharma Research Intelligence position
Industry report
State of Agent Discovery
30-day industry report
The levers are the listing surface agents actually read: names, descriptions, keywords, tool metadata, and registry health. Which lever matters depends on where discovery breaks, which is what continuous measurement shows.
As of 2026-09-29, Inductive Bio competes with AdisInsight, Clinical Trials, Amass Connector, Maven Bio, Boltz API, Cortellis CMC Intelligence, EDEN by Basecamp Research, ICD-10 Codes, Open Targets, Synthesize Bio, Convoke, Cortellis Competitive Intelligence, DocCheck Flexikon, DocNexus Advanced Search MCP, mcp.gosset.ai, OFF-X Safety Assistant, PubCrawl, Rhizome AI in Claude Biomedical & Pharma Research Intelligence, ranked by public Discoverability Score.
As of 2026-09-29, Inductive Bio ranks #9 of 19 in Claude Biomedical & Pharma Research Intelligence with a Discoverability Score of 0/100 (Invisible).
This profile uses the geography attached to the latest public registry snapshot: US. Locale tags are intentionally omitted.